Research Study

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study Low Dose Study
Principal Investigator 
Sean Barbour

Overview

Body Locations and Systems 
Kidney Disease
ClinicalTrials.gov# 
NCT01560052
Status 
Recruiting
Study Start/End 
Aug 16, 2013 to Dec 31, 2018
Locations 
St. Paul's Hospital, Vancouver General Hospital
Name/Title 
Zainab Sheriff, Research Coordinator
Phone 
604-682-2344 ext.64744
Purpose of Study 

This study will evaluate the long-term efficacy and safety of oral methylprednisolone on a background of routine RAS inhibitor therapy, in preventing kidney events in patients with IgA nephropathy and features suggesting a high risk of progression

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.